The Quick Guide to Sleep Apnea SOAP Note

Sleep apnea documentation has become a high-stakes game where one missing sentence can mean a denied sleep study, rejected CPAP equipment, or failed quality measure.

I've watched excellent clinicians lose sleep study authorizations because they wrote "patient snores loudly" instead of documenting witnessed apneas and Epworth Sleepiness Scale scores.

The insurance industry has created incredibly specific documentation requirements for sleep apnea that most medical schools never teach.

They want exact symptom frequencies, validated screening tools, bed partner observations, and failed conservative measures before they'll approve a $2,000 sleep study.

Then after diagnosis, durable medical equipment (DME) suppliers need different documentation to justify CPAP machines, masks, and supplies.

And if you're in value-based care, you're tracking CPAP compliance rates as a quality metric.

Three different documentation requirements for the same condition.

That's why I built SOAP Notes Doctor—to automatically generate notes that satisfy sleep study authorizations, DME requirements, and quality metrics simultaneously.

Let me show you exactly what works.

Why Sleep Apnea Documentation Gets Complicated

Sleep apnea sits at a unique intersection of primary care, sleep medicine, insurance authorization, and DME billing.

Each stakeholder wants different information documented:

Insurance medical directors reviewing sleep study requests want to see that you've ruled out other causes of daytime sleepiness and documented specific apnea symptoms.

DME suppliers providing CPAP equipment need documentation of diagnosis severity (AHI scores), prescribed pressure settings, and mask interface to bill insurance correctly.

Quality improvement programs are increasingly tracking CPAP compliance rates and want documentation of adherence counseling and troubleshooting.

Specialist sleep clinics need your referral documentation to triage patients appropriately between home sleep tests and in-lab polysomnography.

Your notes need to speak all four languages fluently.

The Sleep Study Authorization Challenge

Getting a sleep study approved has become increasingly difficult.

Insurance companies deny sleep study requests constantly, usually citing "insufficient documentation of medical necessity."

Here's what they're actually looking for:

You need to document the triad of symptoms: witnessed apneas, excessive daytime sleepiness, and disrupted sleep quality. Just one or two isn't enough for many insurers.

You should include a quantified sleepiness assessment using the Epworth Sleepiness Scale. Scores greater than 10 significantly strengthen authorization requests.

Document associated conditions that make sleep apnea more likely: obesity, hypertension, atrial fibrillation, type 2 diabetes, or stroke history.

Note whether conservative measures (positional therapy, weight loss, alcohol reduction) have been tried or discussed.

Let me show you how this looks in practice.

Example 1: Initial Sleep Apnea Evaluation and Sleep Study Order

Patient: 48-year-old male
Chief Complaint: Wife concerned about snoring and breathing pauses during sleep
Visit: Sleep apnea evaluation

S – Subjective:

Patient's wife increasingly concerned about his snoring and breathing during sleep. She reports witnessing 10-15 breathing pauses per night where he stops breathing for several seconds, then gasps or snorts. Snoring loud enough to disturb her sleep nightly, now sleeping in separate rooms. Patient reports waking 3-4 times nightly, often with dry mouth or needing to urinate. Denies gasping awake consciously. Significant daytime sleepiness—falls asleep watching TV most evenings, struggles to stay awake during afternoon meetings at work. Has nodded off twice while driving on highway (jolted awake by rumble strips). Morning headaches 3-4 days weekly. Feels unrefreshed despite 7-8 hours in bed. Epworth Sleepiness Scale administered: score 16/24 (abnormal, indicating excessive daytime sleepiness). Denies current CPAP use. Previously told about snoring but never evaluated. Tried nasal strips without benefit.

O – Objective:

Vital Signs: BP 142/88, HR 76, Wt 245 lbs, Ht 5'11", BMI 34.2, Neck circumference 18 inches, O2 sat 96% on room air
General: Obese male, Mallampati class III airway, crowded oropharynx
HEENT: Enlarged uvula, low-lying soft palate, no tonsillar hypertrophy, nasal septum midline
Neck: Thick neck, no thyromegaly
Cardiovascular: Regular rate and rhythm, no murmurs
Respiratory: Clear to auscultation bilaterally
STOP-BANG questionnaire: 6/8 (high risk for OSA: Snoring, Tiredness, Observed apneas, BP elevated, BMI greater than 35, Age greater than 50 no, Neck greater than 40cm yes, Gender male)

A – Assessment:

High clinical suspicion for obstructive sleep apnea based on classic symptom triad: witnessed apneas by bed partner, excessive daytime sleepiness (Epworth 16), and poor sleep quality. Multiple risk factors present including obesity (BMI 34.2), thick neck (18 inches), hypertension, Mallampati class III airway, and high STOP-BANG score (6/8). Daytime sleepiness significantly impacting quality of life and safety (near-miss motor vehicle incidents). Patient meets medical necessity criteria for sleep study evaluation. Contributing factors to HTN may include undiagnosed OSA.

P – Plan:

Sleep Study: Ordered home sleep apnea test (HSAT). Patient appropriate for home testing given high pretest probability and absence of significant cardiopulmonary comorbidities requiring in-lab polysomnography. Study will measure AHI, oxygen desaturations, and sleep position. Results expected in 2 weeks.

Safety Counseling: Strongly advised against driving when sleepy. Discussed risk of motor vehicle accidents with untreated sleep apnea. Encouraged caffeine use for alertness if needed for work safety until treated.

Lifestyle Modifications: Counseled on weight loss goal of 10% body weight which may improve OSA severity. Avoid alcohol within 3 hours of bedtime as it worsens upper airway collapse. Avoid sedating medications before sleep.

Hypertension Management: Discussed that OSA treatment may improve BP control. Will reassess after sleep study results and potential CPAP initiation.

Follow-up: Scheduled visit in 3 weeks to review sleep study results and discuss treatment options if OSA confirmed. Patient educated on likely CPAP therapy if study confirms moderate-severe OSA. Provided educational materials on sleep apnea. Patient verbalized understanding and motivated for testing.

---

Example 2: Sleep Study Results Review and CPAP Initiation

Patient: 56-year-old female
Chief Complaint: Sleep study results follow-up
Visit: OSA diagnosis and treatment initiation

S – Subjective:

Patient returns to discuss home sleep test results completed 1 week ago. Reports study night was typical of her usual sleep. Continues experiencing unrefreshing sleep, waking multiple times nightly, and significant daytime fatigue. Epworth Sleepiness Scale today: 14/24 (unchanged from initial visit). Ready to try treatment as symptoms affecting work performance and energy levels. Concerned about mask claustrophobia based on friend's experience. Husband confirms ongoing loud snoring and witnessed breathing pauses.

O – Objective:

Vital Signs: BP 136/84, Wt 192 lbs, BMI 31.8
Home Sleep Test Results reviewed:

• Total recording time: 7.2 hours
• AHI (Apnea-Hypopnea Index): 28.4 events/hour (moderate OSA)
• Oxygen desaturation index: 24 events/hour
• Lowest oxygen saturation: 84%
• Average oxygen saturation: 93%
• RDI (Respiratory Disturbance Index): 31.2
• Supine AHI: 42.3 (significantly worse in supine position)
• Non-supine AHI: 18.6
• Sleep time in supine position: 64%

A – Assessment:

Moderate obstructive sleep apnea confirmed by home sleep testing with AHI 28.4 events/hour. Significant oxygen desaturations to 84% indicating physiologic impact. Positional component noted with worse apneas in supine position. Patient meets criteria for CPAP therapy per Medicare and insurance guidelines (AHI ≥15). OSA likely contributing to uncontrolled hypertension and daytime symptoms. Without treatment, patient at increased risk for cardiovascular complications, metabolic dysfunction, and motor vehicle accidents.

P – Plan:

CPAP Therapy: Prescribed auto-titrating CPAP (APAP) with pressure range 5-15 cm H2O. This will automatically adjust pressure based on needs throughout night. Referred to DME supplier (ABC Medical) for mask fitting and equipment setup. Recommended nasal pillows or nasal mask interface to minimize claustrophobia concerns. DME will provide in-person training on equipment use, mask fitting, and maintenance.

Positional Therapy: Given significant positional component (supine AHI 42 vs non-supine 18), encouraged avoiding sleeping on back. Can use tennis ball in shirt pocket or positional device. However, CPAP remains primary treatment given overall moderate AHI.

CPAP Compliance: Educated on importance of nightly use for symptom improvement and cardiovascular benefit. Explained that insurance requires 4+ hours use per night for at least 70% of nights during first 90 days to continue coverage. Most patients feel dramatically better within 1-2 weeks of consistent use. Troubleshooting resources available through DME supplier 24/7.

Follow-up Plan: Return visit in 6 weeks to assess CPAP tolerance, review compliance data download, and troubleshoot any issues. Will check BP at that visit as often improves with OSA treatment. DME supplier to provide mask adjustments/changes as needed during first 90 days. Patient to call sooner if unable to tolerate CPAP or significant side effects.

Documentation for DME: Provided diagnosis code (G47.33), AHI value (28.4), and CPAP prescription to DME supplier for insurance billing. Patient has completed face-to-face evaluation within 30 days prior to CPAP setup as required by Medicare/insurance.

---

Example 3: CPAP Compliance Follow-Up and Troubleshooting

Patient: 62-year-old male
Chief Complaint: CPAP follow-up, having difficulties with mask
Visit: CPAP compliance review at 8 weeks

S – Subjective:

Patient on CPAP therapy for 8 weeks following diagnosis of severe OSA (initial AHI 38.2). Reports significant improvement in daytime sleepiness when using CPAP consistently. Wife states his snoring completely resolved on nights he wears it. However, experiencing mask leak issues with current nasal mask—air blowing into eyes, disrupting sleep. Frustrated by this and has stopped using CPAP on 4-5 nights over past 2 weeks due to leak problems. When tolerating well, sleeps through night without waking and feels dramatically more rested. Morning headaches completely resolved. Energy level much improved. Average 5.5 hours nightly when wearing device, but only using 12 nights out of last 14.

O – Objective:

Vital Signs: BP 128/78 (improved from 142/88 pre-treatment), Wt 238 lbs (down 7 lbs from CPAP start)
CPAP Compliance Data (downloaded from device):

• Days used: 48 out of 56 days (86% of nights)
• Average usage on nights used: 5.8 hours
• Days with ≥4 hours use: 42 out of 56 days (75% - meets compliance threshold)
• AHI on therapy: 2.8 events/hour (excellent control, normal is less than 5)
• 95th percentile pressure: 11.2 cm H2O
• Median pressure: 8.4 cm H2O
• Mask leak: 95th percentile 32 L/min (elevated, should be less than 24)
• Leak percentage: 18% of nights with significant leak (elevated)

A – Assessment:

Severe obstructive sleep apnea, on CPAP therapy with excellent therapeutic response when using device (AHI reduced from 38.2 to 2.8 on therapy). Patient meeting Medicare/insurance compliance requirements at 75% usage ≥4 hours. Significant clinical improvement: daytime sleepiness resolved, morning headaches eliminated, blood pressure improved, quality of life enhanced. However, mask leak issues interfering with optimal adherence. Current leak rate elevated at 32 L/min. Mask interface change needed to optimize therapy and prevent future non-compliance. Patient highly motivated to continue therapy given dramatic symptom improvement.

P – Plan:

Mask Interface Change: Contacted DME supplier to schedule mask refit. Recommended trial of full face mask or different nasal mask style to address leak issues. Patient within 90-day mask adjustment period covered by insurance. DME to provide 2-3 mask options for patient to trial.

CPAP Settings: Current pressure settings appropriate based on residual AHI of 2.8 (excellent control). No pressure adjustment needed. Auto-titrating algorithm working well with 95th percentile pressure at 11.2.

Compliance Reinforcement: Praised patient for meeting compliance requirements and encouraged continued nightly use. Emphasized that consistent use provides ongoing cardiovascular protection and symptom control. Reviewed that missing even occasional nights can lead to symptom recurrence.

Blood Pressure: BP improved to 128/78 from 142/88 pre-CPAP. Discussed continuing current antihypertensive regimen. May be able to reduce medications in future if BP remains controlled, but will reassess in 3 months.

Follow-up: Return in 3 months for routine CPAP check after mask issue resolved. Annual sleep study not indicated as patient showing excellent response to therapy. Will continue monitoring compliance data remotely through DME supplier portal. Patient to contact office if new issues arise or unable to resolve leak problem with mask change.

Documentation: Updated compliance data in chart for insurance continuation of CPAP supplies. Patient meeting all requirements for ongoing coverage: greater than 70% nights with greater than 4 hours use, AHI improved to less than 5 on therapy, clinical benefit demonstrated.

---

Essential Documentation Elements for Sleep Apnea

After reviewing thousands of sleep apnea authorizations and DME claims, here's what you absolutely need:

For Sleep Study Authorization:

Epworth Sleepiness Scale score - Quantified measure of daytime sleepiness that reviewers specifically look for

Witnessed apneas - Bed partner observations carry significant weight with medical reviewers

Sleep-related symptoms - Document snoring frequency/loudness, gasping awake, morning headaches, unrefreshing sleep, nocturia

Daytime consequences - Falling asleep during meetings, driving, watching TV. Safety concerns strengthen authorization.

STOP-BANG score - Many insurers now require validated screening tool documentation

Conservative measures tried or discussed - Weight loss counseling, positional therapy, alcohol avoidance

For CPAP Prescription and DME:

Specific AHI value from sleep study - DME billing requires exact number, not just "moderate OSA"

Diagnosis code - Use G47.33 for obstructive sleep apnea

Pressure prescription - Document prescribed pressure range (e.g., "APAP 5-15 cm H2O")

Mask interface type - Specify nasal, nasal pillows, or full face mask

Face-to-face visit within 30 days - Required by Medicare before CPAP setup

For Compliance Monitoring:

Usage hours - Document average nightly use and percentage of nights used

Residual AHI on therapy - Shows treatment is working (goal less than 5 events/hour)

Symptom improvement - Document specific symptoms that resolved with CPAP

Compliance percentage - Must meet ≥4 hours per night for ≥70% of nights

Troubleshooting efforts - Document mask changes, pressure adjustments, or other interventions for side effects

Common Documentation Mistakes That Cause Denials

I've seen countless sleep study requests denied and CPAP claims rejected due to documentation gaps.

Here are the most frequent problems:

"Patient snores" without witnessed apneas → Snoring alone doesn't meet medical necessity criteria. You need documented breathing pauses.

No validated screening tool → Writing "high risk for sleep apnea" without ESS or STOP-BANG scores often triggers denials.

Missing daytime sleepiness documentation → Some reviewers deny studies if there's no documented impact on daytime function.

Ordering in-lab sleep study without justification → Home sleep tests cost less, so insurers want documentation of why in-lab study is medically necessary.

CPAP prescription without specific AHI value → DME suppliers can't bill without the exact AHI from the sleep study report.

No 30-day face-to-face visit documented → Medicare and many insurers require this visit before CPAP, with specific documentation.

Incomplete compliance data → Vague notes like "patient using CPAP" don't satisfy requirements. You need specific hours and percentages.

Documentation Strategy for Different Practice Settings

Primary Care Providers:

Focus your initial evaluation notes on building the case for sleep study authorization: symptoms, validated screening tools, safety concerns, and comorbidities.

After diagnosis, your role shifts to monitoring CPAP compliance and troubleshooting barriers to adherence.

Document specific compliance data at each visit and any interventions you make to improve adherence.

Sleep Medicine Specialists:

Your notes need to satisfy both diagnostic accuracy and treatment precision.

Include detailed interpretation of sleep study results with specific metrics (AHI, oxygen nadirs, sleep architecture).

CPAP titration notes should document pressure settings rationale and mask selection reasoning.

Follow-up notes must include downloaded compliance data with interpretation.

Hospital Medicine:

When managing hospitalized patients with known OSA, document whether they brought their CPAP and if using it during admission.

This affects both quality metrics and patient outcomes.

For patients with suspected but undiagnosed OSA, document your clinical suspicion and recommendation for outpatient sleep study.

How Technology Helps Sleep Apnea Documentation

Modern CPAP machines provide incredible data: nightly usage hours, residual AHI, leak rates, and pressure requirements.

But extracting this data and incorporating it into your notes takes time.

SOAP Notes Doctor can integrate CPAP compliance data directly into your follow-up notes, automatically calculating compliance percentages and highlighting concerning trends.

You can dictate "patient using CPAP average 6.2 hours nightly, 82% of nights, residual AHI 3.1" and the system structures this into properly formatted documentation that satisfies insurance requirements.

For initial evaluations, you can record your clinical assessment and the system ensures you've documented all elements needed for sleep study authorization.

Try it at soapnotes.doctor and see how it streamlines your sleep apnea workflow.

Final Thoughts

Sleep apnea documentation has become surprisingly complex, with different requirements for sleep study authorization, DME billing, and compliance monitoring.

But once you understand what each stakeholder needs, you can document efficiently without excessive time investment.

The key is including validated screening tools, quantified symptoms, specific sleep study metrics, and objective compliance data.

These elements satisfy requirements across authorization, billing, and quality programs while creating clinically useful notes.

Whether you document manually or use SOAP Notes Doctor, focus on the specific data points that drive decision-making: ESS scores, witnessed apneas, AHI values, and compliance percentages.

Your documentation should facilitate appropriate testing, treatment, and monitoring—not create barriers to care.

---

Ready to streamline your sleep apnea documentation?
Visit soapnotes.doctor and generate authorization-ready sleep apnea notes in minutes.